The role of redox status in platelet dysfunction in severe COVID-19-associated pneumonia
- Authors: Osikov M.V.1,2, Antonov V.N.1,3, Zotov S.O.1,3, Ignatova G.L.1,3
-
Affiliations:
- South-Ural State Medical University
- Chelyabinsk Regional Clinical Hospital
- Regional Clinical Hospital No. 3
- Issue: Vol 14, No 3 (2022)
- Pages: 69-78
- Section: Original research
- URL: https://journals.rcsi.science/vszgmu/article/view/109076
- DOI: https://doi.org/10.17816/mechnikov109076
- ID: 109076
Cite item
Abstract
BACKGROUND: Platelet dysfunction in patients with COVID-19 is a well-known fact; however, its formation mechanisms remain unclear.
AIM: To evaluate the role of oxidative stress in dysfunction of platelets in the patients with severe COVID-19-associated pneumonia.
MATERIALS AND METHODS: The study has involved patients with COVID-19 (n = 27) aged 47 to 75 with more than 50% lung damage according to the chest multi-slice computed tomography. The control group has included healthy people comparable in sex and age (n = 24). All the patients have undergone evaluation of the number of platelets in blood, measurement of platelet aggregation induced by adenosine diphosphate, collagen, adrenaline and ristocetin and the level of lipid peroxidation and protein oxidative modifications products in platelet-rich plasma. The calculation and analysis of the obtained data has been carried out using the IBM SPSS Statistics v. 23.
RESULTS: For the patients with severe COVID-19, a decrease in the number of platelets in the blood is characteristic. Acceleration of platelet aggregation induced by collagen and ristocetin has been observed on the 1st day, with the induction of adenosine diphosphate, collagen, adrenaline and ristocetin — on the 8th day of the admission. Oxidative stress in COVID-19 leads to a significant increase in the level of primary markers of protein oxidative modifications in the platelets and an increase in the level of products of primary and secondary lipid peroxidation markers in the platelets. A direct correlation between the products of lipid peroxidation and protein oxidative modifications in the platelets and their aggregation has been found.
CONCLUSIONS: The following study deepens the knowledge of the status of oxidative stress in SARS-CoV-2 infection, confirming its important role in the pathogenesis of COVID-19. The growth of protein oxidative modifications and lipid peroxidation products in patients with severe COVID-19-associated pneumonia in the course of the disease may be one of the causes of platelet dysfunction and, as a result, lead to lethal thrombotic complications.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Mikhail V. Osikov
South-Ural State Medical University; Chelyabinsk Regional Clinical Hospital
Email: prof.osikov@yandex.ru
ORCID iD: 0000-0001-6487-9083
SPIN-code: 7919-2947
Scopus Author ID: 16040195100
MD, Dr. Sci (Med.), Professor
Russian Federation, Chelyabinsk; ChelyabinskVladimir N. Antonov
South-Ural State Medical University; Regional Clinical Hospital No. 3
Email: ant-vn@yandex.ru
ORCID iD: 0000-0002-3531-3491
SPIN-code: 5660-2160
Scopus Author ID: 56638963000
ResearcherId: F-9640-2017
MD, Dr. Sci (Med.), Professor
Russian Federation, Chelyabinsk; ChelyabinskSemen O. Zotov
South-Ural State Medical University; Regional Clinical Hospital No. 3
Author for correspondence.
Email: semenz2007@yandex.ru
ORCID iD: 0000-0001-7469-2386
Russian Federation, Chelyabinsk; Chelyabinsk
Galina L. Ignatova
South-Ural State Medical University; Regional Clinical Hospital No. 3
Email: iglign@mail.ru
ORCID iD: 0000-0002-0877-6554
SPIN-code: 3582-5784
MD, Dr. Sci (Med.), Professor
Russian Federation, Chelyabinsk; ChelyabinskReferences
- Yang X, Yang Q, Wang Y, et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J Thromb Haemost. 2020;18(6):1469–1472. doi: 10.1111/jth.14848
- Xu XR, Zhang D, Oswald BE, et al. Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Crit Rev Clin Lab Sci. 2016;53(6):409–430. doi: 10.1080/10408363.2016.1200008
- Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2021;113(1):45–57. doi: 10.1007/s12185-020-03029-y
- Warkentin TE, Kaatz S. COVID-19 versus HIT hypercoagulability. Thromb Res. 2020;196:38–51. doi: 10.1016/j.thromres.2020.08.017
- Assinger A, Kral JB, Yaiw K, et al. Human cytomegalovirus-platelet interaction triggers toll-like receptor 2-dependent proinflammatory and proangiogenic responses. Arterioscler Thromb Vasc Biol. 2014;34(4):801–809. doi: 10.1161/ATVBAHA.114.303287
- Guo L, Feng K, Wang YC, e al. Critical role of CXCL4 in the lung pathogenesis of influenza (H1N1) respiratory infection. Mucosal Immunol. 2017;10(6):1529–1541. doi: 10.1038/mi.2017.1
- Chen W, Lan Y, Yuan X, et al. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect. 2020;9(1):469–473. doi: 10.1080/22221751.2020.1732837
- Zhang S, Liu Y, Wang X, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. 2020;13(1):120. doi: 10.1186/s13045-020-00954-7
- Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. doi: 10.1111/jth.14768
- Camini FC, da Silva Caetano CC, Almeida LT, de Brito Magalhães CL. Implications of oxidative stress on viral pathogenesis. Arch Virol. 2017;162(4):907–917. doi: 10.1007/s00705-016-3187-y
- Ntyonga-Pono MP. COVID-19 infection and oxidative stress: an under-explored approach for prevention and treatment? Pan Afr Med J. 2020;35(Suppl 2):12. doi: 10.11604/pamj.2020.35.2.22877
- Derouiche S. Oxidative stress associated with SARS-Cov-2 (COVID-19) increases the severity of the lung disease — a systematic review. J Infect Dis Epidemiol. 2020. doi: 10.23937/2474-3658/1510121
- Cecchini R, Cecchini AL. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med Hypotheses. 2020;143:110102. doi: 10.1016/j.mehy.2020.110102
- Federal clinical guidelines Prevention, diagnosis and treatment of a new coronavirus infection (COVID-19), 15 version 02.02.2022 [Internet]. Available from: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/059/392/original/ВМР_COVID-19_V15.pdf. Accessed: 15.09.2022. (In Russ.)
- Llitjos JF, Leclerc M, Chochois C. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18(07):1743–1746. doi: 10.1111/jth.14869
- Warkentin TE, Kaatz S. COVID-19 versus HIT hypercoagulability. Thromb Res. 2020;196:38–51. doi: 10.1016/j.thromres.2020.08.017
- Patell R, Khan AM, Bogue T. et al. Heparin induced thrombocytopenia antibodies in Covid-19. Am J Hematol. 2020;95(10):E295–E296. doi: 10.1002/ajh.25935
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-7
- Sugiyama MG, Gamage A, Zyla R, et al. Influenza virus infection induces platelet-endothelial adhesion which contributes to lung injury. J Virol. 2015;90(4):1812–1823. doi: 10.1128/JVI.02599-15
- Aykac K, Ozsurekci Y, Yayla BCC, et al. Oxidant and antioxidant balance in patients with COVID-19. Pediatr Pulmonol. 2021;56:2803–2810. doi: 10.1002/ppul.25549
- Buffinton GD, Christen S, Peterhans E, Stocker R. Oxidative stress in lungs of mice infected with influenza A virus. Free Radic Res Commun. 1992;16:99–110. doi: 10.3109/10715769209049163
- Selemidis S, Seow HJ, Broughton BRS, et al. Nox1 oxidase suppresses influenza a virus-induced lung inflammation and oxidative stress. PLoS One. 2013;8(4):e60792. doi: 10.1371/journal.pone.0060792
- Pincemail J, Cavalier E, Charlier C, et al. Oxidative stress status in COVID-19 patients hospitalized in intensive care unit for severe pneumonia. A pilot study. Antioxidants (Basel). 2021;10(2):257. doi: 10.3390/antiox10020257
- Abdi A, Jalilian M, Sarbarzeh PA, Vlaisavljevic Z. Diabetes and COVID-19: a systematic review on the current evidences. Diabetes Res Clin Pract. 2020;166:108347. doi: 10.1016/j.diabres.2020.108347
- Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–1263. doi: 10.1126/science.abb2507
- Hati S, Bhattacharyya S. Impact of thiol-disulfide balance on the binding of Covid-19 spike protein with angiotensin-converting enzyme 2 receptor. ACS Omega. 2020;5(26):16292–16298. doi: 10.1021/acsomega.0c02125
Supplementary files
